Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes Mellitus
Launched by UNIVERSITY OF SAO PAULO ·
Trial Information
Current as of September 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new smartphone tool called Tia Bete, which uses artificial intelligence (AI) to help people with Type 1 Diabetes manage their insulin doses more easily. Managing Type 1 Diabetes means carefully counting the carbohydrates in meals to know how much insulin to take. This can be hard to do accurately and consistently, especially for children and adults managing the condition daily. The Tia Bete tool gives personalized, real-time advice on how much insulin to use based on each person’s needs, aiming to improve blood sugar control and make life with diabetes a bit easier.
The study is open to both children and adults with Type 1 Diabetes—specifically, kids aged 6 to 18 and adults over 18 years old—who are willing to try using this tool for six months. Participants will have their blood sugar control measured before and after using Tia Bete, and researchers will also check if it helps reduce episodes of very high or low blood sugar. People taking part can expect to use the app regularly and share their experiences with the research team. This trial is important because it could offer a helpful, easy-to-use tool that supports better diabetes management and improves quality of life for many patients.
Gender
ALL
Eligibility criteria
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported